Founder and CTO
Nuclera
A synthetic chemist and chemical biologist by training, Gordon has extensive experience in applying chemical methodology to solve a wide range of problems. He is passionate about leading the development of Nuclera's rapid protein access platform which will accelerate target identification in drug discovery and enable exciting new lines of research across the life sciences. Gordon holds an MSc in Natural Sciences and a PhD in Chemistry, both from the University of Cambridge.